StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) income statement

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3085% below fair value
$1.08−0.27 (-20.00%)

Close on Nov 18, 2026Market cap $33.96MP/E 3.0Yield –

Actinium Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
10617.8%
Net margin
12564.4%
Return on equity, FY2025
-167.0%

Financial strength

Current ratio
4.08
Debt to equity
–
Debt to assets
–
Cash to current liabilities
393.9%

Valuation

P/E ratio
3.0
Price to sales
–
Price to book
1.12
Dividend yield
–

See a number that looks wrong?